Mersana Therapeutics
MRSN
MRSN
53 hedge funds and large institutions have $342M invested in Mersana Therapeutics in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
5% less funds holding
Funds holding: 56 → 53 (-3)
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
Holders
53
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$5.75M | |
| 2 | +$5.69M | |
| 3 | +$3.36M | |
| 4 |
Millennium Management
New York
|
+$2.2M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.48M |
Top Sellers
| 1 | -$5.36M | |
| 2 | -$4.06M | |
| 3 | -$2.11M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$568K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$504K |